Skip to main content
. 2009 Dec 21;15(47):5966–5971. doi: 10.3748/wjg.15.5966

Table 1.

Univariate analysis of the predictors for survival of the 45 patients who underwent radical BDSR for PBD-1 or MBD disease

Characteristic Number of patients Median survival time (mo) Survival rate (%)
P-value
3-yr 5-yr
Overall 45 25 51.7 36.6
Age (yr) 0.466
≤ 65 25 42 56.4 38.7
> 65 20 33 45.5 34.1
Gender 0.314
Male 30 35 47 28.2
Female 15 42 58.2 48.5
CA19-9 (U/mL) 0.519
≤ 35 19 42 51.6 25.8
> 35 19 55 61.5 49.2
No data 7
Bilirubin at admission (mg/dL) 0.368
≤ 1.6 11 NR 53.3 53.3
> 1.6 34 42 50.5 34.1
Bilirubin at operation (mg/dL) 0.149
≤ 1.6 17 55 65.5 43.6
> 1.6 28 29 43.7 31.9
Preoperative biliary drainage 0.632
No 10 35 40 0.0
Yes 35 42 53.8 42.3
Location 0.547
MBD 34 42 51.4 44.1
PBD-1 11 52 51.9 26
LN dissection 0.997
D1 8 42 58.3 29.2
D2 37 52 51.2 42.6
Transfusion 0.832
No 36 42 51.2 39.4
Yes 9 33 47.6 23.8
Size (cm) 0.892
≤ 2.0 26 35 47 39.2
> 2.0 19 52 56.6 33.9
T stage < 0.001
T1 9 NR 100 100
T2 33 35 49.6 31.5
T3 3 16 0.0 0.0
LN stage 0.010
N0 32 52 63.1 42.6
N1 13 25 19.2 19.2
TNM stage 0.012
 Ia 9 NR 100 100
 Ib 23 42 55.8 32.6
IIb 13 25 19.2 19.2
Cell differentiation 0.005
Well 15 NR 87.5 57.5
Moderate 26 33 41.6 33.3
Poor 4 22 0.0 0.0
Perineural invasion 0.180
No 13 NR 71.1 71.1
Yes 32 35 47.7 29.8

BDSR: Bile duct segmental resection; CA19-9: Carbohydrate antigen 19-9; MBD: Middle bile duct cancer; PBD-1: Proximal bile duct cancers; LN: Lymph node; NR: Not reached.